(MedPage Today) — A meta-analysis of 27 randomized clinical trials found very low incidence of suicide-related adverse events among patients with diabetes or obesity on GLP-1 receptor agonists. (JAMA Psychiatry)
Installing safety nets on the…
Source link : https://www.medpagetoday.com/psychiatry/generalpsychiatry/114733
Author :
Publish date : 2025-03-19 17:18:00
Copyright for syndicated content belongs to the linked Source.
